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Summary
 
Fas and Fas-associated death domain (FADD) play a critical role in the homeostasis of different
cell types. The regulation of Fas and FADD-mediated cell death is pivotal to many physiologi-
cal functions. The activation of T lymphocytes by concanavalin A (Con A) inhibited Fas-medi-
ated cell death. We identified that among the several activation signals downstream of Con A
stimulation, mitogen-activated protein (MAP) kinase kinase (MKK) was the major kinase path-
way that antagonized Fas-triggered cell death. MKK1 suppressed FADD- but not caspase-3–
induced apoptosis, indicating that antagonism occurred early along the Fas-initiated apoptotic
cascade. We further demonstrated that activation of MKK1 led to expression of FLIP, a specific
inhibitor of FADD. MKK1 inhibition of FADD-induced cell death was abrogated if induction
of FLIP was prevented, indicating that FLIP mediates MKK1 suppression of FADD-mediated
apoptosis. Our results illustrate a general mechanism by which activation of MAP kinase atten-
uates apoptotic signals initiated by death receptors in normal and transformed cells.
Key words: mitogen-activated protein kinase kinase • Fas-associated death domain protein • 
Fas • FLIP • apoptosis
 
F
 
as (APO-1, CD95) is a 45-kD transmembrane protein
(1) which transmits apoptotic signals upon engagement
by Fas ligand or by specific anti-Fas antibodies. The death
pathway initiated from Fas involves a series of death-
induced molecules (1). Fas-associated death domain protein
(FADD; MORT1)
 
1
 
 is directly recruited to Fas upon Fas en-
gagement (2, 3). FADD then binds caspase-8 (FADD-like
IL-1
 
b
 
–converting enzyme [FLICE] or MACH; references
4–6), followed by eventual activation of caspase-3 (CPP32
[7, 8]). FADD is also recruited to TNFR1 by TNFR1-asso-
ciated death domain protein (TRADD) adapter, and trans-
mits the death signal downstream of TNF binding (9).
More recently, FADD was identified as the common medi-
ator for apoptosis triggered by death receptor (DR)3 and
DR5 (10–14). In addition, FADD is essential for embryo
development (14, 15).
Fas-initiated apoptosis is regulated by a few molecules,
including Bcl-2, Bcl-X
 
L
 
, crmA, and inhibitor of apoptosis
protein (IAP) (1). Of these regulatory molecules, one that
interferes most upstream in the Fas-mediated death cascade
is FLIP (FLAME-1, I-FLICE, CASH, casper), a homo-
logue of FLICE (16–20). Both the short form and long
form of FLIP (FLIP
 
S
 
 and FLIP
 
L
 
) interact with FADD and
FLICE. Overexpression of FLIP suppresses Fas- and TNF-
induced apoptosis (16–18, 20). Increased expression of
FLIP is found in Fas ligand–resistant melanoma cell lines
and in melanoma tumors (16). A viral homologue of FLIP
also prevents DR-induced apoptosis (21).
Fas-induced apoptosis in T lymphocytes is known to be
antagonized by activation through TCRs (22–24). In
search of an activation signal that interferes with Fas-trig-
gered apoptosis, we identified mitogen-activated protein
kinase (MAPK) as the major kinase pathway which inhibits
FADD-mediated cell death. We also demonstrated that
MAPK kinase (MKK) abrogated Fas-initiated apoptosis
through the induction of FLIP expression. Our results re-
veal the molecular mechanism by which activation of
MAPK, mostly through tyrosine kinase receptors and G
 
1
 
Abbreviations used in this paper:
 
 DR, death receptor; FADD, Fas-associated
death domain protein; FLICE, FADD-like ICE; FLIP, FLICE-inhibitory
protein; ICE, IL-1
 
b
 
–converting enzyme; MAPK, mitogen-activated pro-
tein kinase; MKK, MAPK kinase; nt, nucleotide(s); PI, propidium iodide;
RT, reverse transcription.
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protein–coupled receptors, attenuates apoptotic signals ini-
tiated by DRs in normal and transformed cells.
 
Materials and Methods
 
Reagents and Cell Lines.
 
TPA, A23187, and Con A were pur-
chased from Sigma Chemical Co. (St. Louis, MO). PD 098059,
SB 203580, wortmannin, rapamycin, and calphostin c were pur-
chased from Calbiochem Corp. (San Diego, CA). Cyclosporin A
was a gift of Sandoz Pharmaceutical Co. (Taipei, Taiwan). Anti–
human Fas antibody CH-11 (25) was purchased from Upstate
Biotechnology, Inc. (Lake Placid, NY). Anti–mouse Fas antibody
Jo2 was obtained from PharMingen (San Diego, CA). Human T
cell leukemia Jurkat cells (TIB 152) were obtained from the
American Type Culture Collection (Rockville, MD). Thy-
mocytes and splenocytes were isolated from 8-wk-old MRL 
 
1
 
/
 
1
 
and MRL 
 
lpr/lpr
 
 mice (The Jackson Laboratory, Bar Harbor,
ME). Splenic T cells were purified as described previously (26)
and activated with TPA/A23187 for 24 h. Activated splenic T
cells were then washed, and incubated in the presence of IL-2 (10
U/ml) for another 3 d before anti-Fas treatment. For stimulation
of splenic T cells with Con A, glutaraldehyde-fixed B cells TA3
(27) were added as presenting cells.
 
Plasmids.
 
pcDNA3-AU1-FADD (2) and caspase-3 (CPP32/
Yama [28]) were gifts of Dr. Vishva Dixit (University of Michi-
gan, Ann Arbor, MI). The constitutively active form of MKK1,
pMCL-MKK1-N3/S218E/S222D (29), was a gift of Dr. Natalie
G. Ahn (University of Colorado, Boulder, CO). The active mu-
tant of MKK3b [MKK3b(Glu
 
189
 
, Glu
 
193
 
); 30] was a gift of Dr. Ji-
ahuai Han (Scripps Research Institute, La Jolla, CA). The full
length of FLIP long form (
 
2
 
74 to 
 
1
 
1515 nucleotides [nt]) was
isolated by reverse-transcription (RT)-PCR, blunt ended, par-
tially sequenced, and subcloned into the EcoRV site of pcDNA3
(Invitrogen Corp., Leek, The Netherlands) with an HA tag. FLIP
antisense construct contained the antisense sequence of FLIP 
 
2
 
74
to 
 
1
 
615 nt in pcDNA3. Green fluorescence protein expression
vector pGreen Lantern-1 was purchased from GIBCO BRL
(Gaithersburg, MD).
 
Quantitation of FLIP mRNA.
 
2 
 
m
 
g of total RNA was used for
cDNA synthesis by using oligo-dT as primer (31). 1/10 of the
cDNA synthesized was then amplified by using the following
primers: human (h)FLIP
 
L/S
 
 5
 
9
 
, TGT TGC TAT AGA TGT GG;
hFLIP
 
L/S
 
 3
 
9
 
, CAG GTC TAT TCT GTG GA; hFLIP
 
L
 
 5
 
9
 
, ACT
ATG TGG TGT CAG AGG GCC AG; hFLIP
 
L
 
 3
 
9
 
 is the same as
hFLIP
 
L/S
 
 3
 
9
 
; murine (m)FLIP 5
 
9
 
, GTC ACA TGA CAT AAC
CCA GAT TGT; and mFLIP 3
 
9
 
, GTA CAG ACT GCT CTC
CCA AGC.
 
Transfection, Immunoblot, and MAPK Assay.
 
Jurkat T cells and
activated splenic T cells were transfected with the DEAE-dextran
method (32). For 293T cells, transfection was performed using
the calcium phosphate method. Immunoblot was performed ac-
cording to the method described previously (32). MAPK activity
was analyzed by immunoprecipitation of cell lysate with anti-
ERK2 C-14 antibody (Santa Cruz Biotechnology, Inc., Santa
Cruz, CA), and the kinase activity of the immune complex was
determined as described previously (26).
 
Cell Death Measurement.
 
All cultures were performed in RPMI
with 10% FCS (GIBCO BRL), 10 mM glutamine, 100 U/ml
penicillin, 100 
 
m
 
g/ml streptomycin, and 2 
 
3 
 
10
 
2
 
5
 
 M 2-ME. The
extent of apoptosis was determined by propidium iodide (PI)
staining. At the indicated times after treatment with different
agents, cells were harvested, washed twice in PBS, and resus-
pended in hypotonic fluorochrome solution (50 
 
m
 
g/ml PI, 0.1%
sodium citrate, 0.1% Triton X-100 [33]). Cells were placed at
4
 
8
 
C in the dark overnight, and DNA content was analyzed by
FACScan
 
Ò
 
 (Becton Dickinson, Mountain View, CA). The frac-
tion of cells with sub-G
 
1
 
 DNA content was assessed using the
CellFit program (Becton Dickinson). For cells transiently trans-
fected with FADD/MKK1, survival was monitored with cotrans-
fection of green fluorescence protein expression vector pGreen
Lantern-1 (GIBCO BRL [34]). Treated cells were examined us-
ing a fluorescence microscope (Nikon Inc., Melville, NY).
 
Results
 
Inhibition of Fas-mediated Apoptosis in Jurkat T Cells by Con A
Activation Was Mediated by MKK.
 
Anti-Fas antibody CH-11
(25) induced extensive cell death in Jurkat cells (Fig. 1 
 
A
 
).
Activation of Jurkat cells by Con A reduced Fas-activated
cell death from 75 to 20% (Fig. 1 
 
A
 
). The suppression of
cell death was not due to activation-induced secretion of
IL-2, as IL-2 (50 U/ml) by itself did not prevent Fas-acti-
vated apoptosis (not shown). The inhibition of Fas-trig-
gered apoptosis must be due to the activation signal down-
stream of TCR engagement. We tested several signaling
pathways that may be involved in the antagonism of Fas-
induced cell death by using specific inhibitors for each
pathway. The addition of PD 098059, a selective inhibitor
of MKK (35), effectively abrogated the preventive effect of
Con A (Fig. 1 
 
A
 
). Only a weak or minimal reversal effect
was observed from inhibition of other signaling molecules
on Con A–activated Jurkat T cells. The inhibitors tested
included calphostin c, cyclosporin A, SB 203580, wort-
mannin, and rapamycin. Protein kinase C, phosphatidyl-
inositide 3-kinase, and protein kinase B have been impli-
cated to protect against Fas-mediated apoptosis (36, 37), yet
MKK was the major kinase activated by Con A stimulation
that antagonized Fas-initiated cell death. A role of MAPK
in the suppression of Fas-induced T cell death by lectin has
also been recently reported (23). The antiapoptotic activity
of MKK was further confirmed by transient expression of
active MKK1 (29) in Jurkat cells. Transfection of the vector
alone (pcDNA3) did not interfere with Fas-induced apop-
tosis. The induction of MAPK (see below) by MKK1 pre-
vented apoptosis of Jurkat cells triggered by anti-Fas anti-
body (Fig. 1 
 
B
 
). In contrast, the expression of active
MKK3b (30), which led to activation of p38 MAPK (Fig.
1 
 
C
 
), did not increase resistance to Fas-induced apoptosis in
Jurkat cells. Neither MKK1 nor MKK3b alone induces cell
death of Jurkat cells (Fig. 1 
 
B
 
).
 
MAPK Activation Suppressed FADD-induced Apoptosis but
not Caspase-3–induced Cell Death.
 
We next attempted to
identify the stage along the Fas-initiated apoptotic pathway
that was antagonized by MKK. Jurkat cells were transfected
with FADD and caspase-3 (CPP32) together with the vec-
tor or active MKK1 (Fig. 2 
 
A
 
). The cell death induced by
FADD was significantly prevented by cotransfection with
active MKK1. In contrast, overexpression of active MKK1
did not prevent cell death triggered by caspase-3 (Fig. 2 
 
A
 
).
The inhibition by MKK was at the early stage of the Fas- 
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mediated apoptotic pathway. Because only a small fraction
of Jurkat cells (
 
,
 
10%) were transfected with the gene of
interest in the transient assay, we further examined the pre-
ventive effect of MAPK in 293T cells. Tests using green
fluorescence protein indicated a transfection efficient 
 
.
 
50%.
The high efficiency of transfection was demonstrated by
the MAPK activation in 293T cells transfected with active
MKK1 (Fig. 2 
 
C
 
), in which prominent MAPK activity was
detected 6 h after transfection. The activation of MAPK
then subsided, but was still higher than that of the untrans-
fected cells 12 and 24 h after transfection. Transfection of
FADD and caspase-3 also led to extensive cell death of
293T cells as measured by PI staining (Fig. 2 
 
B
 
). The coex-
pression of active MKK1 in 293T cells suppressed the cell
death induced by FADD. Similar to that observed in Jurkat
cells, overexpression of active MKK1 did not rescue the
apoptosis induced by caspase-3. MAPK activation inter-
fered with the Fas-initiated apoptotic cascade at the stage
before the activation of caspase-3.
 
MAPK Activation Induced FLIP Expression.
 
The antago-
nism of FADD-triggered cell death by active MKK1 re-
sembled the inhibitory activity of FLIP. Both the short
form and long form of human FLIP (hFLIP
 
S
 
 and hFLIP
 
L
 
)
interact with FADD and FLICE, and suppress FADD-
induced cell death (16–18, 20). We used primers to detect
the expression of both long form and short form (hFLIP
 
L/S
 
)
or long form only (hFLIP
 
L
 
) by RT-PCR. FLIP expression
in Jurkat cells was induced by T cell activation from stimu-
lation with Con A (Fig. 3 
 
A
 
). The expression profiles of
hFLIP
 
L/S
 
 and hFLIP
 
L
 
 were similar. The optimum induction
of FLIP mRNA was 4 h after Con A activation. The in-
duction of hFLIP
 
L/S
 
 was suppressed in the presence of
MKK inhibitor PD 098059, suggesting that MKK was re-
quired for FLIP expression. We further checked if activa-
tion of MKK1 would lead to induction of FLIP. The en-
Figure 1. Inhibition of anti-Fas–induced apoptosis in Jurkat T cells by
Con A activation was mediated by MKK. (A) Jurkat cells were stimulated
with anti-Fas antibody CH11 (125 ng/ml) and/or Con A (4 mg/ml) in
the absence or presence of the inhibitors for 16 h. DNA content was de-
termined by staining with 20 mg/ml PI and analyzed by FACScanÒ (Bec-
ton Dickinson). The fraction of cells with sub-G1 DNA content was as-
sessed by the CellFit program (Becton Dickinson) and used as percent cell
death. The inhibitors used were calphostin C (CC, 0.5 mM), cyclosporin
A (CsA, 20 mg/ml), PD 098059 (PD, 50 mM), SB 203580 (SB, 20 mM),
wortmannin (W, 100 nM), and rapamycin (R, 20 ng/ml). None of the
inhibitors alone induced DNA fragmentation at the concentrations used.
The result is the average of duplicates 6 SD. Experiments were repeated
twice with identical results. (B) MKK1 but not MKK3 prevented Fas-
mediated apoptosis in Jurkat cells. Jurkat cells were transfected with
pcDNA3, active MKK1 (29), or active MKK3b (30), together with 5 mg
of pGreen Lantern-1 (GIBCO BRL) by the DEAE-dextran method. 30 h
later, half of the transfected cells were treated with CH11 (black bars) and
the other half were untreated (white bars). Viability of cells was determined
after another 15 h by the cells expressing green fluorescence (reference
34). (C) Transfection of MKK3b led to activation of p38 MAPK. Jurkat
cells were transfected with pcDNA3 (Vec) or active MKK3b (MKK3),
and cell extracts were prepared 40 h later. The content of phosphorylated
p38 MAPK (pp38) and p38 MAPK (p38) were determined by immuno-
blots with antiphosphorylated T180/Y182 p38 MAPK antibody (New
England Biolabs, Inc., Beverly, MA) and anti-p38 MAPK antibody C-20
(Santa Cruz Biotechnology, Inc.), respectively.
Figure 2. MAPK activation suppressed FADD-induced apoptosis but
not caspase-3–induced cell death. (A) Jurkat cells were transfected by the
DEAE-dextran method with pcDNA3 (Control), FADD (1 mg), or
caspase-3 (CPP32, 3 mg), together with the vector (Vec) or active MKK1
(3 mg). 3 mg of pGreen Lantern-1 was included in each transfection and
pcDNA3 was used to make a total dose of 10 mg. Viability was deter-
mined 30 h after transfection as described in the legend to Fig. 1. Data are
the average of two independent transfections. 100% viability represents
cells transfected with pGreen Lantern-1 and pcDNA3 only. (B) 293T
cells were transfected by the calcium phosphate method with the same
plasmids used in A. The apoptosis of the transfected cells was determined
by staining with 20 mg/ml PI and analyzed by FACScanÒ (Becton Dick-
inson). The fraction of cells with sub-G1 DNA content was used as per-
cent cell death. (C) Active MKK1 induced MAPK activation. 293T cells
were transfected with active MKK1, and cell extracts were prepared at the
indicated time points. MAPK was precipitated by anti-ERK2 antibody,
and phosphorylation of myelin basic protein (MBP) was determined by
immunocomplex kinase assay.1798 Interference of FADD-mediated Death by MAPK
dogenous FLIP mRNA in 293T cells was weak but clearly
detectable. Transfection of 293T cells with active MKK1
significantly increased the expression of hFLIPL/S (Fig. 3 B).
The induction was visible 6 h after transfection and peaked
at 24 h. Vector alone did not lead to any increase in
hFLIPL/S mRNA 24 h after transfection. Both the endoge-
nous and the induced expression of FLIP were largely sup-
pressed in the presence of PD 098059 (Fig. 3 B), support-
ing their dependence on MKK.
Antagonism of Fas-mediated Apoptosis in Normal T cells by
Con A Activation Was Mediated by MAPK and FLIP. Be-
cause signaling in lymphoma and in embryonic kidney cells
may be distinct from those in normal T cells, we further
examined whether activation of normal T cells antagonized
Fas-initiated apoptosis. MRL 1/1 thymocytes, known to
express a high level of Fas (38), were stimulated with im-
mobilized anti–mouse Fas antibody Jo2. Significant cell
death of 1/1 thymocytes was detected 4 h after Fas en-
gagement (Fig. 4 A). The apoptosis observed was Fas-spe-
cific because Jo2 did not promote any death in lpr/lpr thy-
mocytes. Con A by itself promoted immature T cell death.
However, costimulation with Con A largely prevented
Fas-mediated apoptosis in thymocytes (Fig. 4 A). The in-
hibitory effect of Con A was abrogated in the presence of
PD 098059 (10 mM). Similar to that observed in Jurkat
cells, Con A activation led to FLIP expression in mouse
thymocytes (Fig. 4 B). The FLIP induction in thymocytes
was significantly earlier than Jurkat cells after Con A activa-
tion. The sensitivity to PD 098059 indicated that Con
A–induced FLIP expression in thymocytes was also depen-
dent on MKK.
In addition to thymocytes, we used mature T lympho-
cytes isolated from spleen. Fas expression in splenic T cells
was induced by TPA/A23187, and T cells were then cul-
tured in the presence of IL-2. Treatment of preactivated
splenic T cells with Jo2 led to extensive cell death (Fig.
5 A). Fas-mediated apoptosis in activated splenic T cells
was prevented by Con A stimulation in a PD 098059–sen-
sitive manner (Fig. 5 A). MKK was also essential for the in-
duction of FLIP in Con A–treated splenic T cells (Fig. 5
B). Therefore, MKK and FLIP antagonized Fas-induced
apoptosis in normal T cells as well as in T lymphomas.
Antagonism of FLIP Induction by Antisense Construct Abro-
gated the Protective Effect of MKK1. We next examined
whether the antiapoptotic effect of MKK was indeed medi-
ated by the induced expression of FLIP. The FLIP cDNA
was obtained using RT-PCR based on the published FLIP
sequence (16, 19). The isolated FLIP effectively prevented
FADD-induced cell death in 293T cells (Fig. 6 A). An an-
tisense construct of FLIP was then prepared which con-
tained the 59 half of FLIP cDNA (274 to 1615 nt) in anti-
sense orientation. The expression of HA-FLIP protein level
was suppressed by 50% when cotransfected with an equal
amount of the FLIP antisense into 293T cells (not shown).
The effectiveness of the FLIP antisense construct was fur-
ther confirmed by inhibition of the FLIP-mediated antiap-
optotic effect (Fig. 6 A). The FLIP antisense construct
alone did not induce cell death in 293T cells. The coex-
pression of the FLIP antisense construct with active MKK1
in Jurkat cells abrogated the suppression of Fas-induced ap-
optosis (Fig. 6 B). The FLIP antisense construct by itself did
not affect the viability of Jurkat cells. Similarly, FADD-
triggered cell death of 293T cells was no longer prevented
by MKK1 when FLIP antisense was cotransfected (Fig. 6 C).
Blockage of FLIP expression by the antisense construct
eliminated the antagonistic effect of MKK1 in Jurkat and
293T cells. This was also the case for normal T lympho-
Figure 3. FLIP expression was
induced by activated MKK. (A)
Jurkat T cells were activated
with Con A in the absence or
presence of PD 098059, and to-
tal RNA was isolated 2, 4, and
6 h after activation. (B) 293T
cells were transfected with active
MKK1 or pcDNA3 (Vec) in the
absence or presence of PD
098059, and RNA was prepared
at the indicated time points. 2 mg
of total RNA was used for
cDNA synthesis by using oligo-
dT as primer. 1/10 of the cDNA
synthesized was then amplified
by using primers specific for
hFLIPL/S (long and short forms),
hFLIPL (long form only), and ac-
tin. 20% of the PCR products
were resolved on an agarose gel
for comparison.
Figure 4. Antagonism of Fas-induced apoptosis in normal thy-
mocytes by Con A activation was mediated by MKK. (A) Freshly iso-
lated thymocytes from 8-wk-old MRL 1/1 and MRL lpr/lpr mice
were stimulated with immobilized anti-Fas antibody Jo2 (coated at 5
mg/ml) and/or Con A (4 mg/ml) in the absence or presence of PD
098059 (PD, 10 mM) for 4 h. Cell death was determined by Annexin
V (Clontech, Palo Alto, CA) staining. Data shown are thymocytes
from  1/1 mice except Jo2 (lpr). The result is the average of duplicates 6
SD. Experiments were repeated twice with identical results. (B) Induc-
tion of FLIP was MKK-dependent in thymocytes. 1/1 thymocytes
were activated with Con A in the absence or presence of 10 mM PD
098059, and total RNA was isolated 1, 2, and 3 h after activation. FLIP
transcript was determined as described in the legend to Fig. 3 except
primers for mFLIP were used during PCR analysis.1799 Yeh et al.
cytes. Even though the transfection efficiency in preacti-
vated splenic T lymphocytes was much lower than Jurkat
cells, transient transfection of active MKK1 conferred resis-
tance of preactivated splenic T lymphocytes to Jo2-induced
apoptosis (Fig. 6 D). The presence of FLIP antisense re-
moved the protective effect of MKK1 in normal T cells.
Therefore, the interference of Fas- and FADD-induced ap-
optosis by MKK was likely mediated by FLIP in different
types of cells.
Discussion
In this study, we illustrated that MAPK activation effec-
tively prevents Fas- and FADD-initiated cell death. In ad-
dition, the death-inhibitory activity of MAPK is likely due
to the induced expression of FLIP. MKK inhibitor PD
098059 suppressed the induction of FLIP in T cells by Con
A (Figs. 3 A, 4 B, and 5 B), and the protective effect of
Con A was abrogated (Figs. 1 A, 4 A, and 5 A). FLIP
mRNA induction reached its optimum 4 h after Con A
stimulation, but decreased thereafter. The transient induc-
tion of FLIP mRNA may seem incompatible with the pro-
longed suppression of Fas- and FADD-triggered cell death
24 h after induction. The prolonged antiapoptotic effect of
FLIP may be due to its location, as demonstrated by both
FLIP and viral FLIP being incorporated in the Fas-contain-
ing death-inducing signaling complex (16, 21). Transient
expression of FLIP may generate enough FLIP protein to
suppress the activity of the death-inducing signaling com-
plex. This was further supported by the fact that the anti-
sense construct of FLIP, which inhibited the expression of
FLIP, eliminated most of the antagonistic effect of MKK1
(Fig. 6, B–D). Induction of FLIP may thus account for most
of the antiapoptotic activity of active MKK1. Notably, the
central role of FLIP in the regulation of Fas-induced apop-
tosis in T cells is supported by increasing evidence. Toso, a
recently identified specific inhibitor of Fas-mediated apop-
Figure 5. Inhibition of Fas-induced apoptosis in preactivated splenic T
cells by Con A activation was mediated by MKK. (A) 1/1 splenic T
cells were purified and activated with TPA/A23187 for 24 h. The cells
were then washed and incubated in IL-2 (10 U/ml) for another 3 d. The
viable cells were recovered by Percoll (Amersham Pharmacia Biotech,
Uppsala, Sweden) and stimulated with anti-Fas antibody Jo2 (coated at 5
mg/ml) and/or Con A (4 mg/ml) in the absence or presence of PD
098059 (PD, 20 mM) for 16 h. For Con A stimulation, 4 3 104 glutaral-
dehyde-fixed TA3 (reference 27) were added in each well. DNA content
was determined by staining with 20 mg/ml PI as described in the legend
to Fig. 1. The result is the average of duplicates 6 SD. Experiments were
repeated twice with identical results. (B) Activated splenic T cells were
stimulated with Con A–fixed TA3 in the absence or presence of 20 mM
PD 098059, and total RNA was isolated 2 and 4 h after activation. FLIP
transcript was determined as described in the legend to Fig. 4.
Figure 6. Antagonism of Fas/FADD-induced apoptosis was abrogated
by inhibition of FLIP induction. (A) Expression of FLIP inhibited
FADD-induced apoptosis, which was abrogated by the FLIP antisense.
293T cells were transfected with 2 mg of FADD, 2 mg of HA-pcDNA3-
FLIP (FLIP), with or without 5 mg of pcDNA3-antisense-FLIP (FLIP-
anti). The fraction of cells with sub-G1 DNA content was determined 24 h
later and used as percent cell death. (B) Coadministration of the FLIP an-
tisense blocked the preventive effect of MKK1 on Fas-induced apoptosis
in Jurkat cells. Jurkat T cells were transfected with pGreen Lantern-1
and/or MKK1, in the presence or absence of 5 mg pcDNA3-antisense-
FLIP. 30 h later, half of the transfected cells were treated with CH11
(black bars) and the other half were untreated (white bars). Viability of cells
was determined after another 15 h by the cells expressing green fluores-
cence in a 5-mm2 area (reference 34). Numbers are averages of five inde-
pendent measurements. (C) Coadministration of FLIP antisense reversed
the antagonist effect of MKK1 on FADD-induced death. 293T cells were
transfected with FADD, MKK1, and/or pcDNA3-antisense-FLIP. Per-
cent cell death represents the fraction of cells with sub-G1 DNA content.
(D) FLIP antisense abrogated the protective effect of MKK1 on Fas-initi-
ated apoptosis in normal T cells. Preactivated splenic T cells were trans-
fected with pGreen Lantern-1, vector (Control), or MKK1, in the pres-
ence or absence of 5 mg pcDNA3-antisense-FLIP by the DEAE-dextran
method. Viability was determined as described in B except Jo2 was used
to induce cell death.1800 Interference of FADD-mediated Death by MAPK
tosis, acts through induction of FLIP expression (39). Part
of the mechanism by which IL-2 enhances Fas-mediated T
cell apoptosis is mediated by an inhibition of FLIP expres-
sion (40).
Recent studies indicate that apoptotic signal transmitted
by Fas engagement is enhanced by TCR signals in T hybri-
domas and in mature T cells (41, 42). Similarly, we have
observed that anti-CD3 alone failed to protect Fas-induced
apoptosis of activated splenic T cells (not shown). Our ob-
servation that Con A activation led to inhibition of Fas-ini-
tiated cell death in T cells (Figs. 1, 4, and 5) suggests that
costimulation signals are required for effective antagonism
of FADD-mediated apoptosis. This is consistent with a re-
port on the protection against Fas-induced apoptosis by su-
perantigen and CD28 in mature human T cells (24).
FADD is the apoptotic mediator of several DRs, includ-
ing Fas, TNFR1, DR3, and DR5 (2, 3, 9–14). Hence,
FADD is activated by death signals through the binding of
the Fas ligand, TNF, and TNF-related apoptosis–inducing
ligand (TRAIL), whereas MAPK is activated by engage-
ment of tyrosine kinase receptor, G protein–coupled recep-
tor, and protooncogenes (43, 44). The activation of MAPK
is essential for cell proliferation and mitogenesis, yet its role
in antiapoptosis is less definite. MAPK has been shown to
inhibit apoptosis induced by nerve growth factor depriva-
tion in PC12 cells (45). MAPK has also been demonstrated
to be involved in the inhibition of ceramide-induced apop-
tosis by sphingosine 1-phosphate (46) and in the suppression
of cardiac myocyte apoptosis by cardiotrophin 1 (47). Be-
cause of the diverse biological targets of MAPK, the mech-
anism of MAPK in the antagonism of apoptosis remains
mostly elusive. This study reveals a novel mechanism by
which MAPK antagonizes FADD-mediated death through
the induction of a FADD inhibitor. Therefore, the antago-
nism of FADD-initiated apoptosis by MKK represents an
interesting cross-talk between two distinct signaling path-
ways, one apoptotic and the other mitogenic. Given the
range of physiological functions and pathological conse-
quences mediated by DRs, the antagonism of FADD by
MKK illustrates how the early stage of DR-induced apop-
tosis can be interrupted. Interestingly, the Fas-activated apop-
totic process is accompanied by an early cleavage of Raf-1,
the activator of MKK (48). In this manner, the antiapop-
totic MKK pathway is inhibited during the progression of
the death pathway. Further molecular characterization of the
antagonism between FADD and MKK will help efforts to
place DR-mediated apoptosis under the appropriate control.
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